Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01114425
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 3)

Communicable Diseases (Phase 3)

HIV Infections (Phase 3)

Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6